Cuban’s Drug Price War: Transparency, Savings, and the Billionaire’s Question
In a recent WIRED interview, Mark Cuban discussed his pharmaceutical company, Cost Plus Drugs, highlighting its success in disrupting the industry by offering transparent pricing and significantly lower drug costs. Cuban claims the company has lowered prices daily for 18 months, resulting in potential billion-dollar savings for Medicare. He also commented on his move from X to Bluesky, citing Bluesky’s superior troll-blocking and engagement features, contrasting it with X’s current state under Elon Musk’s ownership. Cuban believes Bluesky offers a more genuine social networking experience.